TriSalus Life Sciences, Inc. Current Liabilities
TriSalus Life Sciences, Inc. (TLSI) had Current Liabilities of $11.17 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $11.17M.
- 2026-03-31: Liabilities, Current $11.79M.
- 2025-12-31: Liabilities, Current $11.50M.
- 2025-09-30: Liabilities, Current $10.91M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.17M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $11.79M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $11.50M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $10.91M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $9.32M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $11.75M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $10.23M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $9.92M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $12.00M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $14.39M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $14.69M 10-K/A · filed 2025-05-30 | |
| 2023-09-30 | $9.30M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $6.03M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $4.66M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $32.36M 10-K · filed 2024-04-11 | $2.50M 10-K · filed 2023-03-22 |
| 2022-09-30 | $1.91M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.74M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $2.08M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.60M 10-K · filed 2023-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |